Genentech uses Complete Genomics' sequencing service to compare primary lung tumor, a

[News]

Complete Genomics Inc., a third-generation human genome sequencing company, today announced that Genentech Inc., a wholly owned member of the Roche Group, used the company's sequencing, bioinformatics and analytics services to sequence and compare a patient's primary lung tumor and adjacent normal tissue.

More... (http://www.news-medical.net/news/20100527/Genentech-uses-Complete-Genomics-sequencing-service-to-compare-primary-lung-tumor-adjacent-normal-tissue.aspx)